Colfax-backed DJO Global, a global provider of medical technologies, completed the acquisition of Mathys, a Switzerland-based company that develops and distributes products for artificial joint replacement, synthetic bone graft solutions, and sports medicine. The transaction is expected to close in the third quarter of 2021, subject to receipt of applicable regulatory approvals and the satisfaction of other closing conditions. Financial terms were not disclosed. “Combining these two leading orthopedic businesses into one global platform creates an exciting opportunity to build on the strengths of both Mathys and DJO in developing and delivering the next generation of orthopedic innovations,” Benjamin Reinmann, Managing Director, Mathys CEO.